MAM
MRTX

Monaco Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Monaco Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,985
Closed -$452K – 88
2022
Q4 		$452K Sell
9,985
-7,015
-41% -$454K 0.14% 66
2022
Q3 		$1.19M Sell
17,000
-43,000
-72% -$3.18M 0.46% 38
2022
Q2 		$4.03M Buy
60,000
+54,000
+900% +$3.43M 1.75% 17
2022
Q1 		$493K Buy
+6,000
New +$614K 0.2% 41

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Monaco Asset Management's MRTX Position: Q1 2023 in Review

Monaco Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2023, closing a stake of 9,985 shares — an estimated $452K sold.

Monaco Asset Management first reported a position in MRTX in Q1 2022 and held it in 4 quarters. The position peaked at $4.03M in Q2 2022. 221 funds tracked by Wall St. Rank hold MRTX as of Q1 2023.

  • Monaco Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Monaco Asset Management sold 9,985 Mirati Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $452K.
  • Monaco Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Monaco Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $4.03M in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Monaco Asset Management's 13F filing for Q1 2023, filed 11 May 2023.